Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study

Although Bacillus Calmette Guérin (BCG) remains a mainstay of adjuvant treatment in high-risk, non-muscle-invasive bladder cancer, BCG failure occurs in up to 40% of patients, with radical cystectomy (RC) as the inevitable therapeutic consequence. Current data suggest that PD-L1 immunosuppressive si...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Renate, Lindner, Andrea Katharina, Schäfer, Georg, Tulchiner, Gennadi, Staudacher, Nina, Mayr, Martin, Comperat, Eva, Orme, Jacob J., Schachtner, Gert, Thurnher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917772/
https://www.ncbi.nlm.nih.gov/pubmed/33672843
http://dx.doi.org/10.3390/jcm10040764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917772/
https://www.ncbi.nlm.nih.gov/pubmed/33672843
http://dx.doi.org/10.3390/jcm10040764

Ejemplares similares